BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20467358)

  • 1. Natural history of Graves' Ophthalmopathy.
    Benbassat CA; Robenshtok E
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():174-7. PubMed ID: 20467358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grave's ophthalmopathy (GO), are the extrathyroidal manifestations of Grave's disease. Foreword.
    Krassas GE; Bartalena L; Benbassat C
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():173. PubMed ID: 20509231
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of Graves' ophthalmopathy.
    Bartalena L
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):371-9. PubMed ID: 22632372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
    Azzam I; Tordjman K
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of Graves' ophthalmopathy.
    Stiebel-Kalish H; Robenshtok E; Gaton DD
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():178-81. PubMed ID: 20467359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice. Graves' ophthalmopathy.
    Bartalena L; Tanda ML
    N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?
    Anagnostis P; Boboridis K; Adamidou F; Kita M
    J Endocrinol Invest; 2017 Mar; 40(3):257-261. PubMed ID: 27664101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical issues on Graves' ophthalmopathy.
    Rocchi R
    MLO Med Lab Obs; 2006 May; 38(5):10-2, 14-5; quiz 16-7. PubMed ID: 16761864
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
    Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy.
    Eckstein A; Esser J; Mann K; Schott M
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():198-203. PubMed ID: 20467363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric aspects in Graves' orbitopathy.
    Gogakos AI; Boboridis K; Krassas GE
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine therapy and Graves' ophthalmopathy.
    Sisson JC; Schipper MJ; Nelson CC; Freitas JE; Frueh BR
    J Nucl Med; 2008 Jun; 49(6):923-30. PubMed ID: 18483104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Graves' orbitopathy in Latin America: an international questionnaire study compared with Europe.
    Ramos HE; Diehl LA; Camacho CP; Perros P; Graf H;
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):951-6. PubMed ID: 18462263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroidectomy remains an effective treatment option for Graves' disease.
    Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA
    Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.